Company intelligence / Profile preview

Biowell Technology

Taiwan

Ownership: Private
Development stage: Other

Overview

Biowell Technology provides commercial DNA biotechnology products and molecular diagnostic services. Their offerings include human genetic testing for disease risk prediction, paternity tests with TAF certification, plant virus detection for agriculture, pet pathogen screening, animal blood identification for pedigree verification, and avian gender determination using PCR. The company operates advanced laboratories certified to CNLA National Laboratory standards.

Therapeutic areas: Infectious DiseasesOther
Modalities: DNA-based diagnosticsMolecular biology assaysPCR-based testing
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Biowell Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biowell Technology.

Explore the full profile